Research Reports

Key takeaways

Revenue decreased 9.0% to $43.1M, driven by a decline in orders from MCs for medical materials following a temporary increase in procurement in the prior year.

Gross profit fell 19.6% to $30.3M, primarily due to lower franchising revenue with relatively high gross margin.

Operating income declined 26.8% to $17.7M, reflecting lower gross profit partially offset by decreases in office, utility and other expenses and the depreciation of JPY.

Net income dropped 47.4% to $11.3M, largely due to the absence of a prior-year gain on life insurance policies.

Operating cash flow improved to $9.2M from $1.9M, reflecting improved working capital management.

Full analysis

Fee Restructuring and Procurement Normalization Drove Top-Line Decline

Revenue for the first quarter of fiscal 2026 was $43.1 million, a decrease of 9.0% compared to $47.3 million in the same period last year. This decrease was mainly due to a decline in orders from MCs for medical materials, reflecting a temporary increase in procurement activities associated with the business expansion of MCs in the same period of the prior year.

Margin Compression Reflected Revenue Mix Shift

Net Income Halved by Prior-Year Life Insurance Gain

Operating income decreased 26.8% to $17.7 million, primarily due to lower gross profit, partially offset by decreases in office, utility and other expenses and the depreciation of JPY, as well as an increase in consulting and professional service fees. Net income declined 47.4% to $11.3 million, largely due to the absence of a prior-year gain on life insurance policies.

SBCWW · SBC Medical Group Holdings Incorporated

Summary

Key takeaways

Full analysis

Fee Restructuring and Procurement Normalization Drove Top-Line Decline

Margin Compression Reflected Revenue Mix Shift

Net Income Halved by Prior-Year Life Insurance Gain

Operating Cash Flow Strengthened Significantly

Solid Liquidity Position Supports Growth Strategy